07.06.2017 • News

Shell Expands Alcohols at Geismar

(c) Shell
(c) Shell

Shell Chemical has made a final investment decision to expand mid-cut and low-cut fatty alcohol capacity at its plant in Geismar, Louisiana, USA, to meet growing demand for surfactant and plasticizer alcohols.

The company did not disclose the size of the expansion but said it plans to start commercial production of incremental alcohols at the same time as its fourth linear alpha olefins (LAO) unit, which is under construction and on track to start commercial operations by the end of 2018.

Increasing Geismar’s alcohol capacity helps Shell to adapt to changing market conditions by internally consuming both mid-cut linear alpha olefin and internal olefin feedstocks, the company stated.

The 425,000 t/y LAO plant is one of Shell’s largest investments in the US, noted Graham van’t Hoff, executive vice president for the group’s global chemicals business. Ethylene feedstock for the facility will be sourced from Shell’s Norco and Deer Park sites nearby. Once the expansion is completed, total capacity at Geismar will be 1.3 million t/y, making it the largest alpha olefins production site in the world.

Site preparations are also underway for Shell’s proposed petrochemicals complex in Pennsylvania, which will produce 1.6 million t/y of polyethylene using ethane produced from shale gas in the Marcellus and Utica basins. Main construction is scheduled to start in late 2017 with commercial production expected sometime after 2020.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.